DMD and Duchenne muscular dystrophy: However, outcomes have varied across diseases; in one study, gentamicin treatment in patients with DMD and Becker Muscular Dystrophy did not lead to detectable dystrophin re-expression, highlighting the context-dependent efficacy of aminoglycoside-based therapies [35,36].